UK PM Johnson says Indian government not behind Covid vaccine supply delay

Boris Johnson said on Thursday that a delay in the supply of COVID-19 vaccine from the SII in India to Britain was due to technical issues and not because of any intervention by the Indian government

Boris Johnson
Photo: Reuters
Reuters LONDON
1 min read Last Updated : Mar 18 2021 | 11:43 PM IST

LONDON (Reuters) - British Prime Minister Boris Johnson said on Thursday that a delay in the supply of COVID-19 vaccine from the Serum Institute in India to Britain was due to technical issues and not because of any intervention by the Indian government.

"I want to thank the Serum Institute of India for their heroic role in producing huge quantities of vaccine," Johnson said at a news conference in Downing Street in response to a question about whether there was "vaccine nationalism" at play on the Indian side.

"There is a delay ... as there is very frequently in vaccine rollout programmes," he said.

Pressed on whether the Indian government had stopped exports of vaccine to Britain, Johnson said: "No, no, there is a delay as there often is, caused for various technical reasons, but we hope to continue to work very closely with the Serum Institute, and indeed with partners around the world including on the European continent."

 

(Reporting by Guy Faulconbridge and Estelle Shirbon; editing by Michael Holden)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Boris JohnsonCoronavirus Vaccine

First Published: Mar 18 2021 | 11:41 PM IST

Next Story